ArcaScience Raises €6.5M to Transform Drug Development with AI-Powered Benefit-Risk Intelligence
The round was led by The Moon Venture, with participation from Pléiade Venture, Plug and Play Ventures, Bpifrance, and AKKA Technologies. This…
Rethinking Drug Development Decisions: How Advanced Risk – Benefit Models Can Prevent Billion-Dollar Mistakes
Bringing a new drug to market is one of the most ambitious – and riskiest – undertakings in modern science….
Meet the Founder: Bacely YoroBi, the Ethical Hacker Building Human-Centric Cybersecurity
At a time when cybersecurity threats are growing more sophisticated, Scorton is rethinking the industry’s reactive mindset. By blending AI…
Romain Clément Interview: Building ArcaScience to Solve Healthcare’s Biggest R&D Challenge
The pharmaceutical industry faces a sobering reality: 90% of drug candidates fail to reach market, with successful drugs costing an…
RAISE Summit 2025: World’s Leading AI Event
The second edition of RAISE Summit, recognised as the world’s leading artificial intelligence event, concluded successfully on 9th July 2025…
Can AI Redefine Artistic Creativity?
AI and the Future of Work: Preserving the Human Touch in a Tech-Driven World Sofia Balducci attended VivaTech in Paris,…
Joue-La Comme SportsTech Platform Connects Professional Athletes Directly with Fans
Joue-La Comme, a Paris-based sports technology startup, has launched the beta version of its immersive fan engagement platform, designed to…